Webster, MD, is Senior Fellow at the Center for U.S
Back Lau, J, Bloch, K, Schffer, L, et al (24 Sept 2015) 'Discovery of the once-weekly glucagon-like peptide-1 (glp-1) analogue Semaglutide', Journal Medicinal Chemistry , 58/18
Summary A targeted and individualized nutrition and physical activity regimen should be instituted for each patient with a focus on optimizing protein intake and performing frequent resistance training in order to minimize loss of muscle mass while promoting the loss of fat mass
Pharmacol Res (2020) 152:104615
This consistency across nearly all patients suggests that when properly dosed and supported, these medications can address fundamental biological barriers to weight loss
For our patients, we see GLP-1s as the first step in an extraordinary journey to true vitality. References 1